Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$47,973,750
-$32,702,250 QoQ
Shares Held
825,000
-54.2% QoQ
Ownership
0.853%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Commodore Capital LP holds $1,469,900,983 across 32 Biotechnology names. XENE ranks #13 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
17,000,000 | $169,150,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
3,275,000 | $128,380,000 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
2,888,007 | $111,159,389 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
1,912,380 | $96,460,447 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
2,475,000 | $94,792,500 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
2,696,616 | $85,536,659 | |
| 7 | NUVL |
Nuvalent, Inc.
|
833,600 | $85,402,320 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
750,000 | $62,467,500 |
All Filings in XENE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,973,750 | 825,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $80,676,000 | 1,800,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $108,405,000 | 2,700,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $94,682,500 | 3,025,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $78,003,750 | 2,325,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $107,408,000 | 2,740,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $106,299,000 | 2,700,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $107,388,831 | 2,754,266 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $93,323,488 | 2,167,793 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $99,848,545 | 2,167,793 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $63,025,200 | 1,845,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $71,032,500 | 1,845,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $66,032,550 | 1,845,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $65,418,746 | 1,659,111 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $57,577,045 | 1,594,932 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,517,831 | 1,594,932 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $36,763,879 | 1,202,613 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,055,536 | 1,090,126 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,853,720 | 579,432 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,076,376 | 326,336 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $5,394,916 | 301,392 | Shares | Sole | 2021-10-14 | |
| 2020-12-31 | $7,188,119 | 467,368 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||